TABLE 1.
Cross-classified outcomes of arthritis surveillance criteria based on doctor-diagnosed arthritis, chronic joint symptoms, and symptoms onset.
| Sub-Population | DDx | CJS | S-3M | Frequency (%) |
DDx+ (%) |
CJS+, DDx− (%) |
Total (%) |
|
|---|---|---|---|---|---|---|---|---|
| Sex | Age (Year) | N = 33,672 | ||||||
| Men | 18–64 | 1,740 (15.0) | 2,242 (19.3) | 11,597 (34.4) | ||||
| + | + | + | 1,260 (3.7) | |||||
| + | − | . | 405 (1.2) | |||||
| + | + | − | 75 (0.2) | |||||
| − | + | + | 1,849 (5.5) | |||||
| − | − | . | 7,615 (22.6) | |||||
| − | + | − | 393 (1.2) | |||||
| Women | 18–64 | 2,734 (20.0) | 2,294 (16.7) | 13,697 (40.7) | ||||
| + | + | + | 2,002 (5.9) | |||||
| + | − | . | 608 (1.8) | |||||
| + | + | − | 124 (0.4) | |||||
| − | + | + | 1,856 (5.5) | |||||
| − | − | . | 8,669 (25.7) | |||||
| − | + | − | 438 (1.3) | |||||
| Men | ≥65 | 1,511 (43.5) | 545 (15.7) | 3,474 (10.3) | ||||
| + | + | + | 980 (2.9) | |||||
| + | − | . | 469 (1.4) | |||||
| + | + | − | 62 (0.2) | |||||
| − | + | + | 477 (1.4) | |||||
| − | − | . | 1,418 (4.2) | |||||
| − | + | − | 68 (0.2) | |||||
| Women | ≥65 | 2,704 (55.1) | 660 (13.5) | 4,904 (14.6) | ||||
| + | + | + | 1,958 (5.8) | |||||
| + | − | . | 608 (1.8) | |||||
| + | + | − | 138 (0.4) | |||||
| − | + | + | 581 (1.7) | |||||
| − | − | . | 1,540 (4.6) | |||||
| − | + | − | 79 (0.2) | |||||
The null value (.) indicates that the value for the symptoms onset was not available due to a negative affirmation for recent chronic joint symptoms criterion.
CJS: chronic joint symptoms; DDx: doctor-diagnosed arthritis; S-3: symptoms onset exceeded 3 months